Patents by Inventor Christian Flohr

Christian Flohr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or class II molecules for vaccine
    Patent number: 9289478
    Abstract: The present invention relates to novel formulations of tumor-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules as vaccines for the use in immunotherapeutic methods. In particular, the present invention relates to formulations for the immunotherapy of cancer, in particular renal and brain cancer, in particular glioma, especially glioblastoma cancer. The present invention furthermore relates to vaccine compositions for eliciting anti-tumor immune responses.
    Type: Grant
    Filed: April 23, 2009
    Date of Patent: March 22, 2016
    Assignee: IMMATICS BIOTECHNOLOGIES GMBH
    Inventors: Peter Lewandrowski, Christian Flohr
  • Formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or class II molecules for vaccines
    Patent number: 9283267
    Abstract: The present invention relates to novel formulations of tumor-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules as vaccines for the use in immunotherapeutic methods. In particular, the present invention relates to formulations for the immunotherapy of cancer, in particular renal and brain cancer, in particular glioma, especially glioblastoma cancer. The present invention furthermore relates to vaccine compositions for eliciting anti-tumor immune responses.
    Type: Grant
    Filed: January 9, 2012
    Date of Patent: March 15, 2016
    Assignee: IMMATICS BIOTECHNOLOGIES GMBH
    Inventors: Peter Lewandrowski, Christian Flohr
  • NOVEL FORMULATIONS OF TUMOUR-ASSOCIATED PEPTIDES BINDING TO HUMAN LEUKOCYTE ANTIGEN (HLA) CLASS I OR CLASS II MOLECULES FOR VACCINES
    Publication number: 20120107337
    Abstract: The present invention relates to novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules as vaccines for the use in immunotherapeutic methods. In particular, the present invention relates to formulations for the immunotherapy of cancer, in particular renal and brain cancer, in particular glioma, especially glioblastoma cancer. The present invention furthermore relates to vaccine compositions for eliciting anti-tumour immune responses.
    Type: Application
    Filed: January 9, 2012
    Publication date: May 3, 2012
    Applicant: IMMATICS BIOTECHNOLOGIES GMBH
    Inventors: Peter LEWANDROWSKI, Christian FLOHR
  • NOVEL FORMULATIONS OF TUMOUR-ASSOCIATED PEPTIDES BINDING TO HUMAN LEUKOCYTE ANTIGEN (HLA) CLASS I OR CLASS II MOLECULES FOR VACCINE
    Publication number: 20100158929
    Abstract: The present invention relates to novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules as vaccines for the use in immunotherapeutic methods. In particular, the present invention relates to formulations for the immunotherapy of cancer, in particular renal and brain cancer, in particular glioma, especially glioblastoma cancer. The present invention furthermore relates to vaccine compositions for eliciting anti-tumour immune responses.
    Type: Application
    Filed: April 23, 2009
    Publication date: June 24, 2010
    Applicant: IMMATICS BIOTECHNOLOGIES GMBH
    Inventors: Peter LEWANDROWSKI, Christian FLOHR
  • Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
    Publication number: 20040186063
    Abstract: This invention features a compound of the following formula:
    Type: Application
    Filed: August 20, 2003
    Publication date: September 23, 2004
    Inventors: Hans-Jurgen Gutke, Christian Flohr, Albert Beck, Simona Margutti, Mary Eggers, Jan-Hinrich Guse, Moussa Khobzaoui, Michael Burnet